Dive Brief: Amazon has received emergency use authorization from FDA for a direct-to-consumer kit for at-home, unsupervised self-collection of COVID-19 samples. The tech giant first landed an EUA for its Amazon Real-Time RT-PCR Test for Detecting SARS-CoV-2 in March. In later filings, Amazon subsidiary STS Lab Holdco secured clearance for self-collection and a second EUA for a DTC product. Amazon established laboratories in Kentucky and the U.K. to process COVID-19 tests for employees that could serve as a launchpad for entering the wider diagnostics market. Dive Insight: Amazon has been edging into healthcare for years, acquiring online pharmacy PillPack in 2018 before disclosing its on-demand healthcare service earlier this year. As COVID-19 spread, Amazon initiated an in-house COVID-19 testing service for employees, initially in the U.S. and later in the U.K. The site in the U.K. has now reportedly processed 900,000 samples.